According to a study of more than 5.5 million adults aged 50 years or older, vaccination with the bivalent BA.1 mRNA booster ...
Separate VSD analyses confirmed no increased risk of all-cause mortality, cardiac mortality, or non-COVID mortality in the 28 ...
WASHINGTON — The U.S. will likely begin distributing a third vaccine against COVID-19 in the next week, and health officials are girding for questions about which one is best. The Johnson & Johnson ...
European regulators have approved Moderna Inc.’s novel combination flu and Covid shot, handing a victory to the embattled ...
More than three-quarters of American adults didn't get a COVID shot last season, a figure that healthcare experts warn could rise this year amid new U.S. government recommendations. The COVID vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results